Figure 1

There was a significant trend for a stepwise increase in observed/predicted left ventricular mass (LVM) (P<0.001 for trend) (a) and the prevalence of inappropriate LVM (60.0%, 71.1% and 86.7%, respectively; P=0.003 for trend) (b) corresponding to the advancement in chronic kidney disease from stage 3 to stage 5.